Solara Active Pharma Sciences Limited (SOLARA.BO)
Solara Active Pharma Sciences Limited operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Chennai, TN, IN. The stock last traded at $511.05, down 1.47% on the session, giving a market capitalisation of $24.68B. Its beta of 0.89 implies it has historically moved less than the broad market.
Solara Active Pharma Sciences Limited, an Indian enterprise headquartered in Chennai and established in 2017, is a prominent entity in the Active Pharmaceutical Ingredients (API) sector. The company's operations span the entire API value chain, encompassing manufacturing, processing, formulation, sales, distribution, and trading, serving both the domestic Indian market and international clients through imports and exports. Its comprehensive API portfolio caters to an extensive range of therapeutic categories. This includes compounds for cardiovascular conditions, various infections (bacterial, viral, fungal, parasitic), neurological and psychiatric disorders, metabolic ailments (such as diabetes and hyperlipidemia), inflammatory diseases, and a multitude of other specialized medical applications. Beyond its core API production, Solara provides specialized Contract Research and Manufacturing Services (CRAMS) for APIs. These offerings encompass custom development and manufacturing, advanced analytical support, synthesis of impurities, and crucial regulatory guidance. The company maintains a significant global footprint, actively exporting its products and conducting business across major international regions, including Asia Pacific, Europe, North America, and South America. The firm adopted its current name, Solara Active Pharma Sciences Limited, in March 2017, having previously operated as SSL Pharma Sciences Limited.
Solara Active Pharma Sciences Limited is most often compared with the following Healthcare names: